Inventor
SPRANKLE KELLY G
US15 patents
⚠️ This page may combine multiple inventors who share the name “SPRANKLE KELLY G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
7 patentsUS6222025B1Apr 24, 2001
Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
ISIS PHARMACEUTICALS INC342 citations98
US6166197ADec 26, 2000
Oligomeric compounds having pyrimidine nucleotide (S) with 2'and 5 substitutions
ISIS PHARMACEUTICALS INC417 citations98
US5861493AJan 19, 1999
Process for the synthesis of 2'-O-substituted pyrimidines
ISIS PHARMACEUTICALS INC39 citations96
US5760202AJun 2, 1998
Process for the synthesis of 2'-O-substituted pyrimidines
ISIS PHARMACEUTICALS INC62 citations96
US6316626B1Nov 13, 2001
Amine compounds and combinatorial libraries comprising same
ISIS PHARMACEUTICALS INC35 citations90
US6642367B2Nov 4, 2003
Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom
ISIS PHARMACEUTICALS INC6 citations73
US6750344B1Jun 15, 2004
Amine compounds and combinatorial libraries comprising same
ISIS PHARMACEUTICALS INC1 citations44
AMBIT BIOSCIENCES CORP
5 patentsUS9320739B2Apr 26, 2016
RAF kinase modulator compounds and methods of use thereof
AMBIT BIOSCIENCES CORP6 citations83
US8969587B2Mar 3, 2015
RAF kinase modulator compounds and methods of use thereof
AMBIT BIOSCIENCES CORP8 citations83
US7820657B2Oct 26, 2010
Imidazolothiazole compounds for the treatment of disease
AMBIT BIOSCIENCES CORP13 citations82
US10053430B2Aug 21, 2018
RAF kinase modulator compounds and methods of use thereof
AMBIT BIOSCIENCES CORP1 citations62
US9730937B2Aug 15, 2017
RAF kinase modulator compounds and methods of use thereof
AMBIT BIOSCIENCES CORP1 citations62